{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:33:49Z","timestamp":1791178429363,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1097\/01.md.0000119761.27564.c9","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T04:07:57Z","timestamp":1079496477000},"page":"114-122","source":"Crossref","is-referenced-by-count":125,"title":["Risk Factors for Cranial Ischemic Complications in Giant Cell Arteritis"],"prefix":"10.1097","volume":"83","author":[{"given":"Gideon","family":"Nesher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaakov","family":"Berkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Baras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Nesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Rubinow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Sonnenblick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210226","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis.","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"key":"R2-4-20210226","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.38.3.352","article-title":"Neurologic disease in biopsy-proven giant cell (temporal) arteritis.","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"key":"R3-4-20210226","first-page":"1694","article-title":"A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.","volume":"22","author":"Chakravarty","year":"1995","journal-title":"J Rheumatol"},{"key":"R4-4-20210226","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0735-1097(02)02701-8","article-title":"Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men.","volume":"41","author":"Chia","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R5-4-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R6-4-20210226","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000030185.67510.C0","article-title":"Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant cell arteritis.","volume":"106","author":"Cid","year":"2002","journal-title":"Circulation"},{"key":"R7-4-20210226","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/bmj.303.6806.825","article-title":"Thrombocytosis and ischemic complications in giant cell arteritis.","volume":"303","author":"De Keyser","year":"1991","journal-title":"Br Med J"},{"key":"R8-4-20210226","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0161-6420(98)91033-8","article-title":"Scalp necrosis with giant cell arteritis.","volume":"105","author":"Dudenhoefer","year":"1998","journal-title":"Ophthalmology"},{"key":"R9-4-20210226","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P","article-title":"Anticardiolipin antibodies and giant cell arteritis. A prospective, multicenter case-control study.","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R10-4-20210226","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/sarh.2001.23499","article-title":"Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis.","volume":"31","author":"Espinosa","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"R11-4-20210226","first-page":"474","article-title":"Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: Association with severe vascular complications.","volume":"90","author":"Espinoza","year":"1991","journal-title":"Am J Med"},{"key":"R12-4-20210226","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/rheumatology\/36.2.251","article-title":"Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis.","volume":"36","author":"Font","year":"1997","journal-title":"Br J Rheumatol"},{"key":"R13-4-20210226","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Predictors and response to treatment.","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R14-4-20210226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients.","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R15-4-20210226","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis.","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R16-4-20210226","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.287.22.2996","article-title":"Temporal arteritis: A cough, toothache, and tongue infarction.","volume":"287","author":"Hellmann","year":"2002","journal-title":"JAMA"},{"key":"R17-4-20210226","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/01.CIR.0000066907.83923.32","article-title":"Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis. Angiogenic activity of interleukin-6 as a potential protective mechanism.","volume":"107","author":"Hernandez-Rodriguez","year":"2003","journal-title":"Circulation"},{"key":"R18-4-20210226","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.WCB.0000055177.50448.FA","article-title":"Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia.","volume":"23","author":"Herrmann","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"R19-4-20210226","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R20-4-20210226","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R21-4-20210226","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/rheumatology\/33.7.648","article-title":"Prevalence and evolution of anticardiolipin antibodies in giant cell arteritis during corticosteroid therapy. A prospective study of 20 consecutive cases.","volume":"33","author":"Kerleau","year":"1994","journal-title":"Br J Rheumatol"},{"key":"R22-4-20210226","first-page":"798","article-title":"Role of interleukin-6 in fever in rats.","volume":"258","author":"LeMay","year":"1990","journal-title":"Am J Physiol"},{"key":"R23-4-20210226","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: A prospective study of 174 patients.","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"R24-4-20210226","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis.","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"R25-4-20210226","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/art.1780310607","article-title":"Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985.","volume":"31","author":"Machado","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R26-4-20210226","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/rheumatology\/37.2.208","article-title":"Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: A study of 40 cases.","volume":"37","author":"Manna","year":"1998","journal-title":"Br J Rheumatol"},{"key":"R27-4-20210226","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/rheumatology\/keg293","article-title":"Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: Influence of corticosteroid therapy.","volume":"42","author":"Martinez-Taboada","year":"2003","journal-title":"Rheumatology"},{"key":"R28-4-20210226","first-page":"1219","article-title":"Sex differences in giant cell arteritis.","volume":"29","author":"Nir-Paz","year":"2002","journal-title":"J Rheumatol"},{"key":"R29-4-20210226","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00002281-199701000-00002","article-title":"Multisystem interactions in the pathogenesis of vasculitis.","volume":"9","author":"Weyand","year":"1997","journal-title":"Curr Op Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.md.0000119761.27564.c9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:04:43Z","timestamp":1785783883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200403000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.md.0000119761.27564.c9","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}